missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. Epstein Barr Virus Mouse anti-Virus, Clone: CS1, Novus Biologicals™

Epstein Barr Virus Mouse anti-Virus, Clone: CS1, Novus Biologicals™

Mouse Monoclonal Antibody

£196.00

Specifications

Antigen Epstein Barr Virus
Clone CS1
Concentration 0.2 mg/ml
Dilution Western Blot 1-2 ug/ml, ELISA
Applications Western Blot, ELISA
View More Specs

Products 1
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
18349183
View Documents
missing translation for 'viewProductCertificates'
Novus Biologicals
NBP3-07792-20UG 		20 μg
£196.00
20µg
View alternative products
Save Up to  »
Please to purchase this item. Need a web account? Register with us today!
Description

Description

Epstein Barr Virus Monoclonal specifically detects Epstein Barr Virus in Virus samples. It is validated for Western Blot, ELISA.
Specifications

Specifications

Epstein Barr Virus
0.2 mg/ml
Western Blot, ELISA
Unconjugated
Mouse
Virus
Epstein Barr Virus, Human herpesvirus type 4, Hypothetical protein BALF1
IgG1 κ
Protein A or G purified
CS1
Western Blot 1-2 ug/ml, ELISA
Monoclonal
Purified
RUO
10 mM PBS with 0.05% BSA
Recombinant fusion protein containing the sequence of bacterial beta-galactosidase and the carboxyl half of EBV-encoded LMP
Primary
Store at 4°C.
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.